PortfoliosLab logo
HCAT vs. AVAH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HCAT and AVAH is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

HCAT vs. AVAH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HCAT:

-0.53

AVAH:

1.57

Sortino Ratio

HCAT:

-0.47

AVAH:

2.65

Omega Ratio

HCAT:

0.95

AVAH:

1.32

Calmar Ratio

HCAT:

-0.38

AVAH:

1.66

Martin Ratio

HCAT:

-1.21

AVAH:

8.57

Ulcer Index

HCAT:

29.49%

AVAH:

15.91%

Daily Std Dev

HCAT:

70.01%

AVAH:

87.75%

Max Drawdown

HCAT:

-93.89%

AVAH:

-94.76%

Current Drawdown

HCAT:

-92.68%

AVAH:

-54.54%

Fundamentals

Market Cap

HCAT:

$314.54M

AVAH:

$1.13B

EPS

HCAT:

-$1.15

AVAH:

$0.03

PS Ratio

HCAT:

1.01

AVAH:

0.54

PB Ratio

HCAT:

0.83

AVAH:

1.17

Total Revenue (TTM)

HCAT:

$311.47M

AVAH:

$2.09B

Gross Profit (TTM)

HCAT:

$128.83M

AVAH:

$670.41M

EBITDA (TTM)

HCAT:

-$22.50M

AVAH:

$142.56M

Returns By Period

In the year-to-date period, HCAT achieves a -39.32% return, which is significantly lower than AVAH's 28.23% return.


HCAT

YTD

-39.32%

1M

9.16%

6M

-47.23%

1Y

-36.82%

5Y*

-31.35%

10Y*

N/A

AVAH

YTD

28.23%

1M

30.51%

6M

1.03%

1Y

136.29%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HCAT vs. AVAH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HCAT
The Risk-Adjusted Performance Rank of HCAT is 2222
Overall Rank
The Sharpe Ratio Rank of HCAT is 2121
Sharpe Ratio Rank
The Sortino Ratio Rank of HCAT is 2222
Sortino Ratio Rank
The Omega Ratio Rank of HCAT is 2323
Omega Ratio Rank
The Calmar Ratio Rank of HCAT is 2525
Calmar Ratio Rank
The Martin Ratio Rank of HCAT is 1616
Martin Ratio Rank

AVAH
The Risk-Adjusted Performance Rank of AVAH is 9292
Overall Rank
The Sharpe Ratio Rank of AVAH is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of AVAH is 9292
Sortino Ratio Rank
The Omega Ratio Rank of AVAH is 8989
Omega Ratio Rank
The Calmar Ratio Rank of AVAH is 9191
Calmar Ratio Rank
The Martin Ratio Rank of AVAH is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HCAT vs. AVAH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current HCAT Sharpe Ratio is -0.53, which is lower than the AVAH Sharpe Ratio of 1.57. The chart below compares the historical Sharpe Ratios of HCAT and AVAH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

HCAT vs. AVAH - Dividend Comparison

Neither HCAT nor AVAH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HCAT vs. AVAH - Drawdown Comparison

The maximum HCAT drawdown since its inception was -93.89%, roughly equal to the maximum AVAH drawdown of -94.76%. Use the drawdown chart below to compare losses from any high point for HCAT and AVAH. For additional features, visit the drawdowns tool.


Loading data...

Volatility

HCAT vs. AVAH - Volatility Comparison

The current volatility for Health Catalyst, Inc. (HCAT) is 18.23%, while Aveanna Healthcare Holdings Inc. (AVAH) has a volatility of 20.04%. This indicates that HCAT experiences smaller price fluctuations and is considered to be less risky than AVAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

HCAT vs. AVAH - Financials Comparison

This section allows you to compare key financial metrics between Health Catalyst, Inc. and Aveanna Healthcare Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00M20212022202320242025
79.61M
559.22M
(HCAT) Total Revenue
(AVAH) Total Revenue
Values in USD except per share items

HCAT vs. AVAH - Profitability Comparison

The chart below illustrates the profitability comparison between Health Catalyst, Inc. and Aveanna Healthcare Holdings Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%35.0%40.0%45.0%50.0%20212022202320242025
43.6%
32.8%
(HCAT) Gross Margin
(AVAH) Gross Margin
HCAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Health Catalyst, Inc. reported a gross profit of 34.69M and revenue of 79.61M. Therefore, the gross margin over that period was 43.6%.

AVAH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Aveanna Healthcare Holdings Inc. reported a gross profit of 183.56M and revenue of 559.22M. Therefore, the gross margin over that period was 32.8%.

HCAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Health Catalyst, Inc. reported an operating income of -17.50M and revenue of 79.61M, resulting in an operating margin of -22.0%.

AVAH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Aveanna Healthcare Holdings Inc. reported an operating income of 51.91M and revenue of 559.22M, resulting in an operating margin of 9.3%.

HCAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Health Catalyst, Inc. reported a net income of -20.67M and revenue of 79.61M, resulting in a net margin of -26.0%.

AVAH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Aveanna Healthcare Holdings Inc. reported a net income of 5.19M and revenue of 559.22M, resulting in a net margin of 0.9%.